News

Dow posts narrow loss after Fed signals it's in no hurry to cut rates: Live updates
The 30-stock Dow lost 44.14 points, or 0.10%, and ended at 42,171.66. The S&P 500 slipped 0.03% to close at 5,980.87, and the ...
Fierce Biotech15h
Scholar Rock's SMA drug helps weight loss patients on Zepbound retain muscle in phase 2 trial
Scholar Rock’s investigational spinal muscular atrophy drug helped patients taking Eli Lilly’s obesity blockbuster Zepbound ...
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
Scholar Rock's apitegromab helped preserve muscle mass during tirzepatide-induced weight loss, improving overall body ...
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster drugs Ozempic and Wegovy from the drug shortage list, rejecting a challenge ...
Scholar Rock's drug helps Zepbound patients retain more muscle in trial
Scholar Rock said on Wednesday its experimental drug helped overweight patients preserve more lean mass in a mid-stage trial when used in combination with Eli Lilly's weight-loss treatment Zepbound.
Stars Insider on MSN4h
The Ozempic diet: eating tips for diabetic patients
If you take a GLP-1 medication, like Ozempic, Wegovy, Mounjaro, or Zepbound, you may want to take a look at your diet. These ...